Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US-2025367312-A1 · Dec 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
H Lee Moffitt Cancer Center And Res Institute patents
H Lee Moffitt Cancer Center And Res Institute holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 1 |
| First publication | Aug 4, 2020 |
| Latest publication | Dec 4, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Method and compositions for orally administered contrast agents for MR imaging
US-11207429-B2 · Dec 28, 2021 · US
Pathology case review, analysis and prediction
US-10733726-B2 · Aug 4, 2020 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US-2025367312-A1 · Dec 4, 2025 · US
Method and compositions for orally administered contrast agents for MR imaging
US-11207429-B2 · Dec 28, 2021 · US
Pathology case review, analysis and prediction
US-10733726-B2 · Aug 4, 2020 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 2 |
| Chemistry & Metallurgy | 1 |
| Physics | 1 |